Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immunoglobulin A Nephropathy (IgAN)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04578834
What this trial is testing

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

Who this might be right for
IgA Nephropathy
Novartis Pharmaceuticals 518
Large-scale testing (Phase 3)Active Not RecruitingNCT05799287
What this trial is testing

Telitacicept for IgA Nephropathy (TELIGAN)

Who this might be right for
Primary IgA Nephropathy
RemeGen Co., Ltd. 318
Very early researchNot Yet RecruitingNCT06690359
What this trial is testing

IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients

Who this might be right for
IgA NephropathyMembranous Nephropathy
Beijing Immunochina Medical Science & Technology Co., Ltd. 12
Early research (Phase 1)Study completedNCT05174221
What this trial is testing

Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy

Who this might be right for
Kidney DiseaseGlomerulonephritis
Takeda 17
Post-approval studies (Phase 4)Not Yet RecruitingNCT06528015
What this trial is testing

Efficacy and Safety of Probiotics Combined With Enteric-coated Budesonide Capsules in Patients With Primary IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGAProbioticsBudesonide
Gang Xu 206
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06982040
What this trial is testing

Evaluate the Efficacy and Safety of NTQ5082 Capsules in Patients With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Nanjing Chia-tai Tianqing Pharmaceutical 80
Large-scale testing (Phase 3)Study completedNCT05534919
What this trial is testing

Efficacy and Safety in Chinese Patients with Immunoglobulin a Nephropathy (IgAN) Who Have Completed Study Nef-301

Who this might be right for
Primary Immunoglobulin a Nephropathy (IgAN)
Everest Medicines (Singapore) Pte. Ltd. 21
Testing effectiveness (Phase 2)Study completedNCT05016323
What this trial is testing

Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy.

Who this might be right for
IgA Nephropathy
Jiangsu HengRui Medicine Co., Ltd. 316
Testing effectiveness (Phase 2)Study completedNCT07634744
What this trial is testing

A Phase IIa Study in Primary IgA Nephropathy Patients

Who this might be right for
IgA Nephropathy
S-INFINITY Pharmaceuticals Co., Ltd 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06635772
What this trial is testing

The Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA Nephropathy

Who this might be right for
Immunoglobulin a Nephropathy
Hansoh BioMedical R&D Company 90
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Post-approval studies (Phase 4)Study completedNCT02351752
What this trial is testing

Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study

Who this might be right for
Primary IgA Nephropathy
LLiu 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04557462
What this trial is testing

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Novartis Pharmaceuticals 448
Post-approval studies (Phase 4)Ended earlyNCT02523768
What this trial is testing

Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment

Who this might be right for
GlomerulonephritisIgAN
Centre Hospitalier Universitaire de Saint Etienne 117
Testing effectiveness (Phase 2)Looking for participantsNCT07606352
What this trial is testing

Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy

Who this might be right for
IgAN
Sitala Bio LTD 15
Early research (Phase 1)Study completedNCT05314231
What this trial is testing

Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria

Who this might be right for
Proteinuria
Alexion Pharmaceuticals, Inc. 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07474636
What this trial is testing

Efficacy and Safety Study of HS-10542 for IgA Nephropathy

Who this might be right for
IgANImmunoglobulin A Nephropathy (IgAN)Glomerular Disease
Jiangsu Hansoh Pharmaceutical Co., Ltd. 90
Not applicableUnknownNCT00378443
What this trial is testing

ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT

Who this might be right for
Glomerulonephritis, IGA
Peking University
Testing effectiveness (Phase 2)Study completedNCT01738035
What this trial is testing

The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 150
Large-scale testing (Phase 3)Study completedNCT04541043
What this trial is testing

Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE)

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 119
Next Page